These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4310196)

  • 1. Growth in children with thalassaemia major and effect of two different transfusion regimens.
    Brook CG; Thompson EN; Marshall WC; Whitehouse RH
    Arch Dis Child; 1969 Oct; 44(237):612-6. PubMed ID: 4310196
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth of children with thalassaemia: effect of different transfusion regimens.
    Kattamis C; Touliatos N; Haidas S; Matsaniotis N
    Arch Dis Child; 1970 Aug; 45(242):502-9. PubMed ID: 5506935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Height-weight growth in homozygous beta-thalassemia in relation to transfusional regime].
    Miniero R; Sacchetti L; Isolato V
    Minerva Pediatr; 1977 Jan; 29(1):73-80. PubMed ID: 840203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Data on statural growth and skeletal maturation in thalassemia major as related to blood transfusion therapy].
    Esposito L; Ferrara M; Durante A
    Pediatria (Napoli); 1976 Jun; 84(2):235-46. PubMed ID: 1018993
    [No Abstract]   [Full Text] [Related]  

  • 5. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and sexual maturation in thalassemia major.
    Borgna-Pignatti C; De Stefano P; Zonta L; Vullo C; De Sanctis V; Melevendi C; Naselli A; Masera G; Terzoli S; Gabutti V
    J Pediatr; 1985 Jan; 106(1):150-5. PubMed ID: 3965675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and management of short stature in thalassaemia major.
    Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
    Pomarède R; Girot R; Constant S; Rappaport R
    Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine function in thalassemia major.
    Canale VC; Steinherz P; New M; Erlandson M
    Ann N Y Acad Sci; 1974; 232(0):333-45. PubMed ID: 4369990
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive transfusion therapy in thalassemia major.
    Beard ME; Necheles TF; Allen DM
    Pediatrics; 1967 Nov; 40(5):911-5. PubMed ID: 6075668
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme.
    Rebulla P; Modell B
    Lancet; 1991 Feb; 337(8736):277-80. PubMed ID: 1671122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EFFECTS OF SPLENECTOMY ON STATURE AND WEIGHT INCREASE AND SKELETAL AGE IN THALASSEMICS].
    LOJACONO F; ARCARA G; BELLISA A
    Clin Pediatr (Bologna); 1963 Jul; 45():459-82. PubMed ID: 14111829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Longitudinal growth of patients with homozygote beta-thalassemia during continuous subcutaneous infusion of deferoxamine].
    Krüger N; Stubbe P; Tillmann W; Schröter W
    Dtsch Med Wochenschr; 1986 Jan; 111(5):176-81. PubMed ID: 3943469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day-transfusion centre for patients with thalassaemia major.
    Vance JC
    Lancet; 1975 Apr; 1(7913):967-8. PubMed ID: 48137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of homozygote beta thalassemia in Algiers. A 5-year follow-up of 66 patients].
    Adjrad L; Amara A; Rouabhi F; Girot R; Labie D; Benabadji M
    Presse Med; 1989 May; 18(20):1010-13. PubMed ID: 2524793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of thalassaemia major.
    Modell B; Petrou M
    Arch Dis Child; 1983 Dec; 58(12):1026-30. PubMed ID: 6660889
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of transfusing a patient with nontransfusion-dependent thalassaemia major.
    McIntosh N
    Arch Dis Child; 1976 Jun; 51(6):471-2. PubMed ID: 942243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive transfusion therapy in thalassemia major: an eight-year follow-up.
    Necheles TF; Chung S; Sabbah R; Whitten D
    Ann N Y Acad Sci; 1974; 232(0):179-85. PubMed ID: 4370114
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose tolerance test and insulin levels in children with transfusion-dependent thalassaemia.
    Lee BW; Tan SH; Lee WK; Yap HK; Aw SE; Wong HB
    Ann Trop Paediatr; 1985 Dec; 5(4):215-8. PubMed ID: 2418772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARISON OF SIXTY-SIX PATIENTS WITH THALASSEMIA MAJOR AND THIRTEEN PATIENTS WITH THALASSEMIA INTERMEDIA: INCLUDING EVALUATIONS OF GROWTH, DEVELOPMENT, MATURATION AND PROGNOSIS.
    ERLANDSON ME; BRILLIANT R; SMITH CH
    Ann N Y Acad Sci; 1964 Oct; 119():727-35. PubMed ID: 14219452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.